FDA Inspection 1166046 — HMD Investment Group
The FDA completed an inspection of HMD Investment Group on February 25, 2022 in Doral, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Tobacco.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 25, 2022
- Fiscal Year
- 2022
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Doral, FL (United States)